Drug research and development is the process of bringing a new pharmaceutical drug to the market. This often starts with the basic understanding of a target that is involved in a biological process related to dysfunctions in patients with diseases. The whole process is characterized by complex, time-consuming, costly and high failure rates. Therefore, it's important to choose a partner you can trust to help you on the path to success.
As a frontier biotech service provider, Creative Biolabs deeply understands the difficulty of the new drug research and development process. Thus, we are pleased to share our multidisciplinary experience in all major disease areas, various drug modalities and popular therapy development to support your success.
Based on our outstanding expertise and rich experience, we are dedicated to providing professional drug development consulting services to navigate the pharmaceutical industry for our clients. Our powerful risk-based consulting platform focuses on project assessment, preclinical and clinical drug development. We serve our clients with the most reliable and qualified results to help you make early and right decisions about your project thus reducing investment risk. Please contact us and learn more information and our team will get back to you as soon as possible. We look forward to working with you and we will be your best partner.
Drug Development Consulting
Biological Drugs Development
Peptides mainly refer to molecules containing two to fifty amino acids linked by peptide bonds and molecularly poised between small molecules and proteins. Peptide drugs represent a unique class of pharmaceutical compounds used for prevention, therapy and diagnosis of diseases.
Proteins are macromolecules which made up of one or more polypeptides arranged in a biologically functional way. Protein drugs are protein products with certain biological activities for the prevention and diagnosis of diseases.
Antibody refers to a class of protective immunoglobulin produced due to the stimulation of antigens such as pathogenic bacteria and viruses and can bind specifically to antigens. Antibody drugs which consist of antibody substances are prepared by antibody engineering technology based on cell and gene engineering technology.
Microorganisms, also called microbes, are the collective name of all tiny organisms that are invisible to the naked eye. Antimicrobial drugs refer to any substance that inhibits and kills pathogenic microorganisms and are used to treat infectious diseases.
Small Molecule Drugs Development
Small molecule inhibitors are a class of small molecules that interact with proteins and reduce the biological activity of target proteins. Small molecule inhibitors commonly used in drug research and development at present mainly include enzyme inhibitors and transcription factor inhibitors.
Small molecule antagonists, or sometimes called blockers are substances that act against and block agonist-mediated effects. Antagonists themselves do not induce biological effects.
Agonists can induce excitatory or inhibitory responses and modulate or enhance the basal activity of tissues. Small molecule agonists are substances that can enhance another molecule's activity and therefore stimulate an action. Agonists often mimic the effects of natural substances.
Small molecule activators are opposite to inhibitors. From therapeutic point of view, using small molecular activators to efficiently and selectively activate physiologically relevant biological targets including enzymes has a great therapeutic potential because the low expression of these enzymes is the cause of the observed pathophysiological disorders.
Therapy Development Consulting
Gene therapy is designed to utilize the therapeutic delivery of nucleic acid into a patient's cells to treat or prevent disease. It has become a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections.
Immunotherapy is a type of cancer treatment that stimulates, or enhances the body's own immune system to help fight cancer. Immunotherapy has been approved for the treatment of several cancers, including melanoma, lung cancer, kidney cancer, bladder cancer, lymphoma, etc.
Stem cell therapy is an advanced therapy in which intact, living cells are injected, grafted or implanted into a patient. It involves a diverse group of cell types, such as embryonic stem cells, mesenchymal stem cell and induced pluripotent stem cells can be applied to various therapeutic indications.
Virotherapy is an emerging branch of therapies that explores different viruses to defeat diseases, including congenital genetic, infectious, cardiovascular and autoimmune diseases, especially cancers. With the significant advances in vector engineering, virotherapy has been at the forefront of modern medicine.